IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q1 2023 Holdings

Filed 2023-04-25 | 7 holdings | $82.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ventyx Biosciences Inc(VTYX)COM92332V107$25.0M746,37030.3%
Icosavax IncCOM45114M109$20.4M3,510,22824.6%
Jasper Therapeutics IncCOM471871103$15.4M8,519,64818.7%
Hillevax IncCOM43157M102$9.2M558,92311.2%
Talaris Therapeutics IncCOM87410C104$5.5M2,932,6066.7%
Elevation Oncology IncCOM28623U101$4.5M2,370,1425.4%
Kezar Life Sciences IncCOM49372L100$2.6M828,7113.1%